TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹14,396 Cr | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr | ₹13,653 Cr |
What is the latest Total Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹14,396 Cr |
| Mar2024 | ₹14,505 Cr |
| Mar2023 | ₹14,468 Cr |
| Mar2022 | ₹12,606 Cr |
| Mar2021 | ₹13,653 Cr |
How is Total Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14,396 Cr | -0.76 | |
| Mar2024 | ₹14,505 Cr | 0.26 | |
| Mar2023 | ₹14,468 Cr | 14.77 | |
| Mar2022 | ₹12,606 Cr | -7.67 | |
| Mar2021 | ₹13,653 Cr | - | |
Compare Total Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹143,407.2 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
| MANKIND PHARMA | ₹83,688.0 Cr | -2.6% | -5.6% | -15% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.5% |
5.3% |
40.2% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses